These results indicate that tau can induce deadenylation activity of genes whose expression is deregulated in cancer and/or AD, and this activation is not observed in samples from cells expressing tau phosphorylated at residues implicated in neurological disorders. The gene discussed is MAPT; the disease is cancer.